PharmiWeb.com - Global Pharma News & Resources
15-Jan-2021

Peripheral Embolic Protection Devices Pipeline Assessment, 2020 Report - Stage of Development, Segment, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.


"Peripheral Embolic Protection Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Peripheral Embolic Protection Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Embolic Protection Devices (EPDs) are used to capture and remove plaque debris that is dislodged during interventional procedures.

Scope

  • Extensive coverage of the Peripheral Embolic Protection Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Peripheral Embolic Protection Devices Overview

3 Products under Development

3.1 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development

3.2 Peripheral Embolic Protection Devices - Pipeline Products by Segment

3.3 Peripheral Embolic Protection Devices - Pipeline Products by Territory

3.4 Peripheral Embolic Protection Devices - Pipeline Products by Regulatory Path

3.5 Peripheral Embolic Protection Devices - Pipeline Products by Estimated Approval Date

3.6 Peripheral Embolic Protection Devices - Ongoing Clinical Trials

4 Peripheral Embolic Protection Devices - Pipeline Products under Development by Companies

4.1 Peripheral Embolic Protection Devices Companies - Pipeline Products by Stage of Development

4.2 Peripheral Embolic Protection Devices - Pipeline Products by Stage of Development

5 Peripheral Embolic Protection Devices Companies and Product Overview

6 Peripheral Embolic Protection Devices - Recent Developments

7 Appendix

Companies Mentioned

  • Abbott Vascular Inc
  • AorticLab Sarl
  • Artio Medical
  • Avantec Vascular Corp
  • Capture Vascular Inc
  • Cardio-Flow Ltd.
  • Cardiovascular Systems Inc
  • Emboline, Inc.
  • Filterlex Medical Ltd
  • Innovative Cardiovascular Solutions, LLC
  • Innovia LLC
  • Javelin Medical Ltd
  • Keystone Heart Ltd
  • Marblehead Medical LLC
  • Medtronic Plc
  • MIV Therapeutics Inc
  • Neurosonix Ltd.
  • Protembis GmbH
  • University of Minnesota
  • University of Toledo

For more information about this report visit https://www.researchandmarkets.com/r/o24epx


Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 15-Jan-2021